Home Health News Moderna Sinks on AstraZeneca Covid-19 Vaccine Progress, JPMorgan Downgrade – Investing.com

Moderna Sinks on AstraZeneca Covid-19 Vaccine Progress, JPMorgan Downgrade – Investing.com

3 min read
0
0
83

[ad_1]

© Reuters.
© Reuters.

By Christiana Sciaudone

Investing.com — Moderna (NASDAQ:) dropped 14% after AstraZeneca (NYSE:) and Oxford University said their vaccine candidate showed promise.

The AstraZeneca-Oxford vaccine, AZD1222, is safe and produced an immune response in early-stage clinical trials in healthy volunteers, Reuters reported, citing data from The Lancet. No serious side effects were reported.

JPMorgan (NYSE:) downgraded Moderna, which is working on a separate vaccine candidate, today on a high valuation, to neutral from overweight, The Street reported. Analyst Cory Kasimov boosted his one-year price target to $89 from $60.

Moderna has surged in recent months on vaccine news, quadrupling to more than $80 since March.

Moderna’s vaccine, mRNA-1273, elicited antibodies in all people tested in an initial safety trials, Bloomberg reported last week, though there was a high rate of side effects, with three of 45 people facing severe reactions. Moderna should begin a Phase 3 trial on July 27, The Street said.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Let’s block ads! (Why?)

[ad_2]
Source link

Load More Related Articles
Load More By admin
Load More In Health News

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

UK coronavirus variant cases doubling every 10 days in US, study finds – Fox News

[ad_1] The highly-contagious COVID-19 variant first detected in the United Kingdom is now …